FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2144003531> ?p ?o ?g. }

• W2144003531 endingPage "105" @default.
• W2144003531 startingPage "98" @default.
• W2144003531 abstract "Data from in vitro and animal studies support a neuroprotective role of glatiramer acetate (GA) in multiple sclerosis (MS). We investigated prospectively whether treatment with GA leads to clinical and paraclinical changes associated with neuroprotection in patients with relapsing-remitting (RR) MS. Primary aim of this clinical study was to determine serum BDNF levels in RR-MS patients who were started on GA as compared to patients who remained therapy-naive throughout 24 months. Secondary outcomes included relapses and EDSS, cognition, quality of life, fatigue and depression, BDNF expression levels on peripheral immune cells (FACS, RT-PCR), serum anti-myelin basic peptide (MBP) antibody status, evoked potential and cerebral MRI studies. While GA treatment did not alter serum levels or expression levels on peripheral immune cells of BDNF over time it resulted in a transient increase of serum IgG antibody response to MBP, mainly due to subtype IgG1 (p < 0.05), after 3 months. However, no significant differences were found between GA treated and therapy-naive patients with regard to serum BDNF and intracellular BDNF expression levels, nerve conduction (including median and tibial nerve somatosensory, pattern-shift visual and upper and lower limb motor evoked potentials) or MRI (including volume of hyperintense lesions, volume of hypointense lesions after CE, mean diffusivity and fractional anisotropy) outcome parameters. In conclusion, our findings do not support a major impact of GA treatment on paraclinical markers of neuroprotection in human RR-MS." @default.
• W2144003531 created "2016-06-24" @default.
• W2144003531 creator A5000794291 @default.
• W2144003531 creator A5012263587 @default.
• W2144003531 creator A5013962169 @default.
• W2144003531 creator A5014894550 @default.
• W2144003531 creator A5023347755 @default.
• W2144003531 creator A5033080532 @default.
• W2144003531 creator A5033849863 @default.
• W2144003531 creator A5047098023 @default.
• W2144003531 creator A5052652886 @default.
• W2144003531 creator A5056983959 @default.
• W2144003531 creator A5060017986 @default.
• W2144003531 creator A5060641186 @default.
• W2144003531 creator A5063292690 @default.
• W2144003531 creator A5086932843 @default.
• W2144003531 creator A5091700005 @default.
• W2144003531 date "2015-10-01" @default.
• W2144003531 modified "2023-09-26" @default.
• W2144003531 title "Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial" @default.
• W2144003531 cites W1603728406 @default.
• W2144003531 cites W1933220919 @default.
• W2144003531 cites W1976604523 @default.
• W2144003531 cites W1980374113 @default.
• W2144003531 cites W1990307702 @default.
• W2144003531 cites W1990494404 @default.
• W2144003531 cites W2007108464 @default.
• W2144003531 cites W2010958802 @default.
• W2144003531 cites W2015502121 @default.
• W2144003531 cites W2027657102 @default.
• W2144003531 cites W2035928725 @default.
• W2144003531 cites W2040655178 @default.
• W2144003531 cites W2053836109 @default.
• W2144003531 cites W2055258829 @default.
• W2144003531 cites W2069477663 @default.
• W2144003531 cites W2075235867 @default.
• W2144003531 cites W2077357002 @default.
• W2144003531 cites W2105060097 @default.
• W2144003531 cites W2107277218 @default.
• W2144003531 cites W2112161945 @default.
• W2144003531 cites W2112165124 @default.
• W2144003531 cites W2114796009 @default.
• W2144003531 cites W2120819751 @default.
• W2144003531 cites W2127685830 @default.
• W2144003531 cites W2130632081 @default.
• W2144003531 cites W2133005541 @default.
• W2144003531 cites W2133700559 @default.
• W2144003531 cites W2154982729 @default.
• W2144003531 cites W2161060662 @default.
• W2144003531 cites W2169515058 @default.
• W2144003531 cites W2916040650 @default.
• W2144003531 doi "https://doi.org/10.1016/j.jneuroim.2015.08.004" @default.
• W2144003531 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26439969" @default.
• W2144003531 hasPublicationYear "2015" @default.
• W2144003531 type Work @default.
• W2144003531 sameAs 2144003531 @default.
• W2144003531 citedByCount "7" @default.
• W2144003531 countsByYear W21440035312016 @default.
• W2144003531 countsByYear W21440035312017 @default.
• W2144003531 countsByYear W21440035312018 @default.
• W2144003531 countsByYear W21440035312019 @default.
• W2144003531 countsByYear W21440035312021 @default.
• W2144003531 crossrefType "journal-article" @default.
• W2144003531 hasAuthorship W2144003531A5000794291 @default.
• W2144003531 hasAuthorship W2144003531A5012263587 @default.
• W2144003531 hasAuthorship W2144003531A5013962169 @default.
• W2144003531 hasAuthorship W2144003531A5014894550 @default.
• W2144003531 hasAuthorship W2144003531A5023347755 @default.
• W2144003531 hasAuthorship W2144003531A5033080532 @default.
• W2144003531 hasAuthorship W2144003531A5033849863 @default.
• W2144003531 hasAuthorship W2144003531A5047098023 @default.
• W2144003531 hasAuthorship W2144003531A5052652886 @default.
• W2144003531 hasAuthorship W2144003531A5056983959 @default.
• W2144003531 hasAuthorship W2144003531A5060017986 @default.
• W2144003531 hasAuthorship W2144003531A5060641186 @default.
• W2144003531 hasAuthorship W2144003531A5063292690 @default.
• W2144003531 hasAuthorship W2144003531A5086932843 @default.
• W2144003531 hasAuthorship W2144003531A5091700005 @default.
• W2144003531 hasConcept C126322002 @default.
• W2144003531 hasConcept C143998085 @default.
• W2144003531 hasConcept C160539049 @default.
• W2144003531 hasConcept C170493617 @default.
• W2144003531 hasConcept C203014093 @default.
• W2144003531 hasConcept C25498285 @default.
• W2144003531 hasConcept C2778577042 @default.
• W2144003531 hasConcept C2778609137 @default.
• W2144003531 hasConcept C2778790584 @default.
• W2144003531 hasConcept C2780640218 @default.
• W2144003531 hasConcept C2780876595 @default.
• W2144003531 hasConcept C529278444 @default.
• W2144003531 hasConcept C535046627 @default.
• W2144003531 hasConcept C71924100 @default.
• W2144003531 hasConceptScore W2144003531C126322002 @default.
• W2144003531 hasConceptScore W2144003531C143998085 @default.
• W2144003531 hasConceptScore W2144003531C160539049 @default.
• W2144003531 hasConceptScore W2144003531C170493617 @default.
• W2144003531 hasConceptScore W2144003531C203014093 @default.
• W2144003531 hasConceptScore W2144003531C25498285 @default.

• next